These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23530510)

  • 1. Inflammatory mediators in epilepsy.
    Lorigados Pedre L; Morales Chacón LM; Orozco Suárez S; Pavón Fuentes N; Estupiñán Díaz B; Serrano Sánchez T; García Maeso I; Rocha Arrieta L
    Curr Pharm Des; 2013; 19(38):6766-72. PubMed ID: 23530510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis.
    Kamali AN; Zian Z; Bautista JM; Hamedifar H; Hossein-Khannazer N; Hosseinzadeh R; Yazdani R; Azizi G
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1760-1774. PubMed ID: 33200702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy.
    Strauss KI; Elisevich KV
    J Neuroinflammation; 2016 Oct; 13(1):270. PubMed ID: 27737716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy.
    Paudel YN; Shaikh MF; Shah S; Kumari Y; Othman I
    Eur J Pharmacol; 2018 Oct; 837():145-155. PubMed ID: 30125565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
    Dey A; Kang X; Qiu J; Du Y; Jiang J
    Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.
    Terrone G; Salamone A; Vezzani A
    Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does brain inflammation mediate pathological outcomes in epilepsy?
    Wilcox KS; Vezzani A
    Adv Exp Med Biol; 2014; 813():169-83. PubMed ID: 25012376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.
    Alyu F; Dikmen M
    Acta Neuropsychiatr; 2017 Feb; 29(1):1-16. PubMed ID: 27692004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation in epileptogenesis after traumatic brain injury.
    Webster KM; Sun M; Crack P; O'Brien TJ; Shultz SR; Semple BD
    J Neuroinflammation; 2017 Jan; 14(1):10. PubMed ID: 28086980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inflammation in epileptogenesis.
    Vezzani A; Friedman A; Dingledine RJ
    Neuropharmacology; 2013 Jun; 69():16-24. PubMed ID: 22521336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain inflammation in epilepsy: experimental and clinical evidence.
    Vezzani A; Granata T
    Epilepsia; 2005 Nov; 46(11):1724-43. PubMed ID: 16302852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy.
    Holtman L; van Vliet EA; Aronica E; Wouters D; Wadman WJ; Gorter JA
    Epilepsia; 2013 Apr; 54(4):589-95. PubMed ID: 23398413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological perspectives of temporal lobe seizures.
    Liimatainen S; Lehtimäki K; Palmio J; Alapirtti T; Peltola J
    J Neuroimmunol; 2013 Oct; 263(1-2):1-7. PubMed ID: 23998423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy and brain inflammation.
    Vezzani A; Aronica E; Mazarati A; Pittman QJ
    Exp Neurol; 2013 Jun; 244():11-21. PubMed ID: 21985866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators in human epilepsy: A systematic review and meta-analysis.
    de Vries EE; van den Munckhof B; Braun KP; van Royen-Kerkhof A; de Jager W; Jansen FE
    Neurosci Biobehav Rev; 2016 Apr; 63():177-90. PubMed ID: 26877106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy.
    Srivastava A; Dixit AB; Banerjee J; Tripathi M; Sarat Chandra P
    Clin Chim Acta; 2016 Jan; 452():1-9. PubMed ID: 26506013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.
    Vitaliti G; Pavone P; Mahmood F; Nunnari G; Falsaperla R
    Hum Vaccin Immunother; 2014; 10(4):868-75. PubMed ID: 24609096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.
    Drion CM; van Scheppingen J; Arena A; Geijtenbeek KW; Kooijman L; van Vliet EA; Aronica E; Gorter JA
    J Neuroinflammation; 2018 Jul; 15(1):212. PubMed ID: 30037344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.